Global Health

Support More Work Like This.

Your contribution makes it possible for the Center’s researchers to devise practical, evidence-based solutions for today’s most pressing development challenges.

As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally? How can global health donors and other development partners advance global health security, pandemic preparedness, and health systems strengthening? What can be done to address health inequities in low- and middle-income countries? What are evidence-informed policies to address market failures that span from early-stage pharmaceutical research and development to supply chain efficiency and ensure health product markets work for the poor? 

CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.

Subscribe today to recieve CGD’s latest newsletters and topic updates.

Program Goals

CGD’s Global Health Policy program analyzes the economics of global health challenges, offering practical policy solutions to shape decision-making by policymakers within global health institutions, donor organizations, and governments.  

CGD examines the efficiency and effectiveness of global health practices to expand access, drive greater value-for-money, and align incentives to support global public goods for health – with a particular focus on advancing the equitable provision of essential, quality health services in low- and middle-income countries.

02
An Indian  pharmacist pulls out a box of medicines from a shelf at a Generic Drug Store at the Victoria Hospital in Bangalore on June 28, 2012. The Generic Drug Store which was opened in Bangalore recently by the medical education department in association with the Karnataka State Cooperative Consumer Federation sells branded generic drugs which are priced less than 50 percent of the Maximum Retail Price (MRP). Estimates by Dolat Capital show that the US generic market, currently estimated at USD350 billion
Improving global health procurement, supply chains, and innovation

CGD’s analysis focuses on improving global and local systems to research, develop, regulate, procure, and deploy high-quality, equitable products and services in low-and middle- income countries, while building more robust and resilient health systems.

04
Vital stats on a computer in a hospital; medical professionals in the background
Strengthening priority-setting and value-for-money locally and at global levels

CGD and our International Decision Support Initiative (iDSI) partners work with policymakers and donors to ensure health systems achieve the greatest impact within resource constraints exacerbated by crises like COVID-19 that disrupt essential health services and restrict fiscal space.

01
In this image, a relieved little African girl is looked after by the vaccination staff after she has received her first Covid shot. Source: Riccardo Mayer
Advancing equitable prevention and treatment of COVID-19

CGD provides high-impact research and policy advice to improve the equity and effectiveness of the COVID-19 response at the global, regional, and national levels—with a focus on access to essential, safe, effective, quality-assured health products that represent good value-for-money.

03
Quality Control Laboratory medicine
Rethinking pandemic preparedness and global health security after COVID-19

CGD supports policymakers to secure adequate financing, cohesive governance, and sustainable manufacturing capacity for pandemic preparedness, assess triggers for pandemic response strategies, and shape the market for antibiotics in low- and middle-income countries to address anti-microbial resistance.

05
Cigarette butts crushed into ground, with a scotch glass full in the background
Advancing the agenda of the IFIs on health taxes

CGD works to nudge International Financial Institutions to fully develop their technical support to governments to design and implement effective taxes on tobacco, alcohol, and sugar-sweetened beverages in low- and middle-income countries.

Program Goals

CGD’s Global Health Policy program analyzes the economics of global health challenges, offering practical policy solutions to shape decision-making by policymakers within global health institutions, donor organizations, and governments.  

CGD examines the efficiency and effectiveness of global health practices to expand access, drive greater value-for-money, and align incentives to support global public goods for health – with a particular focus on advancing the equitable provision of essential, quality health services in low- and middle-income countries.

01
In this image, a relieved little African girl is looked after by the vaccination staff after she has received her first Covid shot. Source: Riccardo Mayer
Advancing equitable prevention and treatment of COVID-19

CGD provides high-impact research and policy advice to improve the equity and effectiveness of the COVID-19 response at the global, regional, and national levels—with a focus on access to essential, safe, effective, quality-assured health products that represent good value-for-money.

02
An Indian  pharmacist pulls out a box of medicines from a shelf at a Generic Drug Store at the Victoria Hospital in Bangalore on June 28, 2012. The Generic Drug Store which was opened in Bangalore recently by the medical education department in association with the Karnataka State Cooperative Consumer Federation sells branded generic drugs which are priced less than 50 percent of the Maximum Retail Price (MRP). Estimates by Dolat Capital show that the US generic market, currently estimated at USD350 billion
Improving global health procurement, supply chains, and innovation

CGD’s analysis focuses on improving global and local systems to research, develop, regulate, procure, and deploy high-quality, equitable products and services in low-and middle- income countries, while building more robust and resilient health systems.

03
Quality Control Laboratory medicine
Rethinking pandemic preparedness and global health security after COVID-19

CGD supports policymakers to secure adequate financing, cohesive governance, and sustainable manufacturing capacity for pandemic preparedness, assess triggers for pandemic response strategies, and shape the market for antibiotics in low- and middle-income countries to address anti-microbial resistance.

04
Vital stats on a computer in a hospital; medical professionals in the background
Strengthening priority-setting and value-for-money locally and at global levels

CGD and our International Decision Support Initiative (iDSI) partners work with policymakers and donors to ensure health systems achieve the greatest impact within resource constraints exacerbated by crises like COVID-19 that disrupt essential health services and restrict fiscal space.

05
Cigarette butts crushed into ground, with a scotch glass full in the background
Advancing the agenda of the IFIs on health taxes

CGD works to nudge International Financial Institutions to fully develop their technical support to governments to design and implement effective taxes on tobacco, alcohol, and sugar-sweetened beverages in low- and middle-income countries.

A series of arrows pointing upward, teal and gold gradient background

Results and Impact

Over the last two decades, CGD strengthened results-based financing approaches—such as performance incentives for global health, development impact bonds, and Cash on Delivery Aid strategies—among global health funders, including the Global Fund for AIDS, TB and Malaria, the World Bank, and US and UK governments. In 2009, our research led to the creation of an Advance Market Commitment that helped develop and expand access to pneumococcal vaccines in low- and middle-income countries. And in 2013, CGD co-founded the International Decision Support Initiative (iDSI) to drive the Universal Health Coverage agenda. Since then, iDSI has successfully strengthened priority-setting processes in 9 low- and middle- income countries, building institutional capacity and advising on coverage decisions that affect three billion people.

Most recently, CGD supported the G20 High-Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response, which led to development of a Financial Intermediary Fund at the World Bank.